❌

Reading view

Facile induction of immune tolerance by an interleukin-2–TGFβ surrogate agonist

Nature - Issue - nature.com science feeds

By: Qinli Sun · Alison K. Barrett · Masato Ogishi · Huiyun Lyu · Hua Jiang · Honghui Liu · Yang Zhao · Grayson E. Rodriguez · Pingdong Tao · Matthias Obenaus · Karsten D. Householder · Qizhi Tang · Tobias V. Lanz · K. Christopher Garcia

11 March 2026 at 08:00

Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10208-0

A fusion protein designed to comprise IL-2 and a helminth-derived TGFβ mimic activates IL-2 and TGFβ signalling pathways in IL-2 receptor-expressing T cells and induces stable antigen-specific regulatory T cells in peripheral lymphoid organs.

Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma

Nature - Issue - nature.com science feeds

By: Jiawei Lv · Dan-Xue Zheng · Jin-Hui Liang · Ning Zhang · Zu-Lu Ye · Xu-Dong Xu · Melvin. L. K. Chua · Lu-Lu Zhang · Zi-Ming Du · Zi-Chen Zhang · Wen-Fei Li · Ling-Long Tang · Lei Chen · Yan-Ping Mao · Rui Guo · Yu-Pei Chen · Li Lin · Yuan Zhang · Xu Liu · Cheng Xu · Zhi-Xuan Li · Ling-Xin Xu · Pan-Yang Yang · Kun Chen · Deng Bin · Tian-Sheng Gao · Jian-Ye Yan · Lu-Si Chen · Shao Hui Huang · Hong-Yun Zhao · Shu-Bin Hong · Yu-Sheng Jie · Hui-Ling Huang · Xu-Hua Tang · Jing-Ping Yun · Li-Zhi Liu · Li Tian · Hao-Jiang Li · Ji-Bin Li · Guan-Qun Zhou · Jun Ma · Ying Sun

11 March 2026 at 08:00

Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10244-w

A clinical trial testing whether monitoring ctDNA clearance during treatment for nasopharyngeal cancer could be used to inform decisions about an individual’s subsequent therapeutic programme shows promising results.